Health
Suvoda Introduces Advanced Drug Optimization For IRT to Improve Accuracy of Clinical Trial Drug Supply Management
Greater Control Over Drug Supply Management Helps Sponsors Reduce Costs and Carbon Footprint PHILADELPHIA, Oct. 12, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), an...
2023-10-12 09:00
1940
Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test
SEOUL, South Korea, Oct. 12, 2023 /PRNewswire/ -- Gencurix
2023-10-12 06:00
2026
CSL Signs Renewable-Linked Power Purchase Agreement with AGL to Supply Electricity to Australian Manufacturing Sites
MELBOURNE, Australia, Oct. 12, 2023 /PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) announced today thatit has signed a Renewable-Linked Power Purchase Agreement (PPA) with Australian energy provider, AGL.AGL was awarded the contract after an extensive review of the ener...
2023-10-12 05:00
3570
KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit
SHANGHAI, Oct. 11, 2023 /PRNewswire/ -- Shanghai Kehua Bio-engineering
2023-10-11 16:27
2541
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich
LONDON, Oct. 11, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased to announce the opening of the purpose-built Smith+Nephew Academy Munich, a new centre for surgica...
2023-10-11 14:00
3358
EQT to acquire VetPartners, the leading provider of veterinary and animal health services in Australia and New Zealand
* EQT to acquire VetPartners, the leading provider of veterinary and animal health services across a network of 267 general practice clinics and specialty hospitals inAustralia and New Zealand * With a community of more than 1,300 highly skilled vets and over 3,000 nurses and cli...
2023-10-11 12:21
2003
Ascletis Announces Poster Presentation of Phase II Study Topline Results of FASN Inhibitor ASC40 for Treatment of Acne at EADV Congress 2023
HANGZHOU and SHAOXING, China, Oct. 11, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") today announces the poster presentation of Phase II study topline results of ASC40, a first-in-class fatty acid synthase (FASN) inhibitor for treatment of acne, at the European Academy of Der...
2023-10-11 08:10
2154
VISTA Eye Specialist Achieves International Recognition at European Congress
PETALING JAYA, Malaysia, Oct. 11, 2023 /PRNewswire/ -- Last September, VISTA Eye Specialist proudly marked its presence at the prestigious European Society of Cataract and Refractive Surgery (ESCRS) Symposium and Congress inVienna, Austria. This event, the second participation since the onset of ...
2023-10-11 08:00
2038
JUNG KWAN JANG launches student-specialized brand I.PASS for physical strength, immunity, and memory all at once
- The essential item that Korean parents with high enthusiasm over education provide for their children SEOUL, South Korea, Oct. 11, 2023 /PRNewswire/ -- I.PASS, a student-specialized brand that was renewed and launched through JUNG KWAN JANG red ginseng of KGC (Korea Ginseng Corp.), is a health...
2023-10-11 07:00
2630
EADV Congress: Non-melanoma skin cancer killing more people than melanoma, new study finds
BERLIN, Oct. 11, 2023 /PRNewswire/ -- Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of skin cancer, a new study presented today at the EADV Congress 2023 has found. Researchers also believe that NMSC is underreported and that the...
2023-10-11 06:01
1875
SAFETYscan47: A Valuable Component in Revolutionizing Chemical Risk Assessments for Global Health and Safety
SAN DIEGO, Oct. 10, 2023 /PRNewswire/ -- Eurofins Discovery, an industry-leading provider of products and services for drug discovery research, today announced its SAFETYscan®47 platform as a New Approach Methodology (NAM), part of a standardized framework aiming to revolutionize chemical risk a...
2023-10-10 23:10
1959
Novel classification of allergic disorders published by the European Academy of Allergy and Clinical Immunology: SIAF
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper published in 'Allergy' DAVOS, Switzerland, Oct. 10, 2023 /PRNewswire/ -- The revision of the current allergic disease nomenclature based on symptoms and organ dysfunction has been l...
2023-10-10 19:10
1405
Gates Foundation Celebrates 20 Years of "Grand Challenges" With New Investments and a Call to Make R&D Breakthroughs Available More Quickly and Equitably
Commitments focus on advancing equitable access to artificial intelligence (AI) and vaccines,and catalyzing innovations that address women's health SEATTLE and DAKAR, Senegal, Oct. 10, 2023 /PRNewswire/ -- A slate of new initiatives to support locally led innovation was announced today inDakar b...
2023-10-10 18:30
1608
Scorpion Therapeutics and Pierre Fabre Laboratories Announce First Patient Dosed in Phase 1/2 Clinical Trial of STX-721, a Mutant-Selective EGFR Exon 20 Inhibitor for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer
-- STX-721 is characterized by high selectivity and a potentially best-in-class profile -- -- Scorpion's second program to enter clinical development this year -- -- One of two EGFR programs being developed with Pierre Fabre Laboratories -- BOSTON and CASTRES, France, Oct. 10, 2023 /PRNewswire/...
2023-10-10 18:00
1577
Frost & Sullivan Launches the EmpowerHer Program to Bridge the Growth Gap in Women's Health
Global Think Tanks and Collaboration to Drive Innovation and Empowerment in Women's Health SAN ANTONIO, Oct. 10, 2023 /PRNewswire/ -- Frost & Sullivan, a renowned leader in fostering innovation and driving transformative change, proudly announces the launch of its groundbreaking"EmpowerHer" Grow...
2023-10-10 15:12
1319
Recbio signed a strategic cooperation agreement with Zimbabwe National Biotechnology Administration and ICGEB China Regional Research Centre
TAIZHOU, China, Oct. 10, 2023 /PRNewswire/ -- On October 8, 2023, Dr. Deckster Tonny SAVADYE, CEO of Zimbabwe NBA, and Dr.Yang Yili, International Centre for Genetic Engineering and Biotechnology China Regional Research Centre(ICGEB), visited Recbio. Dr. SAVADYE and his team conducted an on-the-s...
2023-10-10 13:54
4531
Fullerton Health and Connections MindHealth Recommend a Framework for Action to Enhance Mental Health at the Workplace
SINGAPORE, Oct. 10, 2023 /PRNewswire/ -- Fullerton Health & Connections MindHealth are pleased to announce the release of a Healthcare Brief that addresses critical challenges surrounding mental health in the workplace. Titled "A Framework for Action: Enhancing Mental Health in the Workplace", th...
2023-10-10 13:39
3875
Xinhua Silk Road: Chinese dairy giant Yili shares whole-lifecycle nutrition and health innovative practices at Growth Asia Summit 2023 in Singapore
BEIJING, Oct. 10, 2023 /PRNewswire/ -- Chinese dairy giant Inner Mongolia
2023-10-10 12:56
3121
Mental Health is the Foundation for Learning
Education Cannot Wait Executive Director Yasmine Sherif Statement on World Mental Health Day NEW YORK, Oct. 10, 2023 /PRNewswire/ -- Millions of school-aged children, adolescents and their teachers in countries of brutal conflicts, devastating climate disasters and refuge are calling out for our...
2023-10-10 12:01
2092
AffaMed Technologies Announces Licensing of EVOLUX®- a novel extended monofocal intraocular lens (IOL) designed to provide better intermediate vision and equivalent distance vision when compared to a standard monofocal IOL
Expands Portfolio of Cataract Surgery Solutions for Patients in Greater China to New Extended Monofocal Segment AffaMed Therapeutics and SIFI Leadership Celebrate Strong Progress of the AffaMed Technologies Joint-Venture BEIJING, Oct. 10, 2023 /PRNewswire/ -- AffaMed Technologies ("AffaMed"), a ...
2023-10-10 09:00
2596
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 298 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 279 media titles]
2024-11-29 20:33
Most Read
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
2024-11-29 20:33
6075
Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
2024-11-26 13:00
5154